Henry Schein (HSIC) Stock Forecast & Price Target

Compare

405 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HSIC Analyst Ratings

Moderate Buy

5 Buy

7 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Henry

Schein

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HSIC Stock 12 Month Forecast

Average Price Target

$75.00

▲(13.57% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Henry Schein in the last 3 months. The average price target is $75.00 with a high forecast of $83.00 and a low forecast of $70.00. The average price target represents a 13.57% change from the last price of $66.04.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"63":"$63","84":"$84","68.25":"$68.3","73.5":"$73.5","78.75":"$78.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":83,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$83.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$75.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":70,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$70.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[63,68.25,73.5,78.75,84],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,68.39,69.51384615384616,70.6376923076923,71.76153846153846,72.88538461538461,74.00923076923077,75.13307692307693,76.25692307692307,77.38076923076923,78.50461538461539,79.62846153846154,80.7523076923077,81.87615384615384,{"y":83,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,68.39,68.89846153846153,69.40692307692308,69.91538461538461,70.42384615384616,70.93230769230769,71.44076923076923,71.94923076923077,72.45769230769231,72.96615384615384,73.47461538461539,73.98307692307692,74.49153846153845,{"y":75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,68.39,68.51384615384616,68.6376923076923,68.76153846153846,68.88538461538461,69.00923076923077,69.13307692307693,69.25692307692307,69.38076923076923,69.50461538461539,69.62846153846154,69.7523076923077,69.87615384615384,{"y":70,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":70.55,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.94,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.37,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.5,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.2,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.17,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.07,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.46,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.56,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.48,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.98,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.39,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$83.00

Average Price Target$75.00

Lowest Price Target$70.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Owen Mediport

TR | OpenAI - 4o

$76→$74

Hold

12.05%

Upside

Reiterated

09/25/25

AI Generated ArticleAI Generated Article

Allen Lutz

Bank of America Securities

$83

Buy

25.68%

Upside

Reiterated

09/24/25

Henry Schein's Strategic Growth and Shareholder Value Enhancement: A Buy RecommendationWe hosted a fireside chat with Henry Schein’s SVP and at our London today. Schein discussed a handful of items that factor into the 2026 outlook. First, while patient traffic is relatively stable in the U.S., it has picked up slightly internationally, particularly in mainland Europe. Management also expects rate cuts to modestly support equipment sales near term and provide incremental support to DSO de‑ novo activity over time with a more gradual benefit to merchandise sales from market expansion. Henry Schein’s practice design service helps customers design or redesign their practice and is an internal leading indicator for de-novo builds. This service has grown double digits y/y in most months through July.

Michael Petusky

Barrington

$78

Buy

18.11%

Upside

Reiterated

09/23/25

Henry Schein's Growth Potential: Buy Rating Backed by Market Stability and Strategic InitiativesWe also believe that the company will continue to make a material effort to expand the footprint of its relatively small but fast-growing ($400 million) home solutions business.

Jason Bednar

Piper Sandler

$77

Buy

16.60%

Upside

Reiterated

09/23/25

Henry Schein (HSIC) Gets a Buy from Piper Sandler

Elizabeth Anderson CFA

Evercore ISI

$83

Buy

25.68%

Upside

Reiterated

09/10/25

Evercore ISI Sticks to Its Buy Rating for Henry Schein (HSIC)

John Stansel

J.P. Morgan

$80→$76

Buy

15.08%

Upside

Reiterated

08/07/25

J.P. Morgan Keeps Their Buy Rating on Henry Schein (HSIC)

Michael Cherny

Leerink Partners

$75→$72

Hold

9.02%

Upside

Reiterated

08/06/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Henry Schein (NASDAQ: HSIC), Green Thumb Industries (Other OTC: GTBIF) and Recursion Pharmaceuticals (NASDAQ: RXRX)

Jonathan Block

Stifel Nicolaus

$75→$70

Hold

6.00%

Upside

Reiterated

08/06/25

Stifel Nicolaus Keeps Their Hold Rating on Henry Schein (HSIC)

Kevin Caliendo

UBS

$75→$70

Hold

6.00%

Upside

Reiterated

08/06/25

Henry Schein price target lowered to $70 from $75 at UBSHenry Schein price target lowered to $70 from $75 at UBS

Steven Valiquette

Mizuho Securities

$76→$74

Hold

12.05%

Upside

Reiterated

08/06/25

Mizuho Securities Sticks to Its Hold Rating for Henry Schein (HSIC)

Vik Chopra

Wells Fargo

$75→$70

Hold

6.00%

Upside

Reiterated

08/06/25

Henry Schein (HSIC) Receives a Hold from Wells Fargo

Brandon Vazquez

William Blair

―

Hold

―

Reiterated

08/05/25

Cautious Hold on Henry Schein Amid EPS Shortfall and Uncertain Strategic Partnerships

Jeff Johnson

Robert W. Baird

$72

Hold

9.02%

Upside

Downgraded

07/11/25

Hold Rating on Henry Schein Amid Uncertainty Over Heartland Dental's Potential Shift

Erin Wright

Morgan Stanley

$55

Sell

-16.72%

Downside

Reiterated

04/15/25

Morgan Stanley Keeps Their Sell Rating on Henry Schein (HSIC)

Daniel Rich

CFRA

$87

Hold

31.74%

Upside

Upgraded

01/30/25

CFRA upgrades Henry Schein (HSIC) to HoldCFRA analyst Daniel Rich upgraded Henry Schein (NASDAQ: HSIC) from Sell to Hold with a price target of $87.00.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Owen Mediport

TR | OpenAI - 4o

$76→$74

Hold

12.05%

Upside

Reiterated

09/25/25

AI Generated ArticleAI Generated Article

Allen Lutz

Bank of America Securities

$83

Buy

25.68%

Upside

Reiterated

09/24/25

Michael Petusky

Barrington

$78

Buy

18.11%

Upside

Reiterated

09/23/25

Jason Bednar

Piper Sandler

$77

Buy

16.60%

Upside

Reiterated

09/23/25

Henry Schein (HSIC) Gets a Buy from Piper Sandler

Elizabeth Anderson CFA

Evercore ISI

$83

Buy

25.68%

Upside

Reiterated

09/10/25

Evercore ISI Sticks to Its Buy Rating for Henry Schein (HSIC)

John Stansel

J.P. Morgan

$80→$76

Buy

15.08%

Upside

Reiterated

08/07/25

J.P. Morgan Keeps Their Buy Rating on Henry Schein (HSIC)

Michael Cherny

Leerink Partners

$75→$72

Hold

9.02%

Upside

Reiterated

08/06/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Henry Schein (NASDAQ: HSIC), Green Thumb Industries (Other OTC: GTBIF) and Recursion Pharmaceuticals (NASDAQ: RXRX)

Jonathan Block

Stifel Nicolaus

$75→$70

Hold

6.00%

Upside

Reiterated

08/06/25

Stifel Nicolaus Keeps Their Hold Rating on Henry Schein (HSIC)

Kevin Caliendo

UBS

$75→$70

Hold

6.00%

Upside

Reiterated

08/06/25

Henry Schein price target lowered to $70 from $75 at UBSHenry Schein price target lowered to $70 from $75 at UBS

Steven Valiquette

Mizuho Securities

$76→$74

Hold

12.05%

Upside

Reiterated

08/06/25

Mizuho Securities Sticks to Its Hold Rating for Henry Schein (HSIC)

Vik Chopra

Wells Fargo

$75→$70

Hold

6.00%

Upside

Reiterated

08/06/25

Henry Schein (HSIC) Receives a Hold from Wells Fargo

Brandon Vazquez

William Blair

―

Hold

―

Reiterated

08/05/25

Cautious Hold on Henry Schein Amid EPS Shortfall and Uncertain Strategic Partnerships

Jeff Johnson

Robert W. Baird

$72

Hold

9.02%

Upside

Downgraded

07/11/25

Hold Rating on Henry Schein Amid Uncertainty Over Heartland Dental's Potential Shift

Erin Wright

Morgan Stanley

$55

Sell

-16.72%

Downside

Reiterated

04/15/25

Morgan Stanley Keeps Their Sell Rating on Henry Schein (HSIC)

Daniel Rich

CFRA

$87

Hold

31.74%

Upside

Upgraded

01/30/25

CFRA upgrades Henry Schein (HSIC) to HoldCFRA analyst Daniel Rich upgraded Henry Schein (NASDAQ: HSIC) from Sell to Hold with a price target of $87.00.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Henry Schein

1 Month

xxx

Success Rate

11/22 ratings generated profit

Average Return

-0.50%

reiterated a xxx

rating 15 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -0.50% per trade.

3 Months

xxx

Success Rate

20/36 ratings generated profit

Average Return

+1.50%

reiterated a xxx

rating 15 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 55.56% of your transactions generating a profit, with an average return of +1.50% per trade.

1 Year

Jason BednarPiper Sandler

Success Rate

9/22 ratings generated profit

Average Return

-0.45%

reiterated a buy rating 15 days ago

Copying Jason Bednar's trades and holding each position for 1 Year would result in 40.91% of your transactions generating a profit, with an average return of -0.45% per trade.

2 Years

xxx

Success Rate

10/36 ratings generated profit

Average Return

-6.08%

reiterated a xxx

rating 15 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 27.78% of your transactions generating a profit, with an average return of -6.08% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HSIC Analyst Recommendation Trends

Rating

May 25

Jun 25

Jul 25

Aug 25

Sep 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HSIC has received 18 Buy Ratings, 20 Hold Ratings, and 0 Sell Ratings. HSIC average Analyst price target in the past 3 months is 75.00.

Each month's total comprises the sum of three months' worth of ratings.

HSIC Financial Forecast

HSIC Earnings Forecast

Next quarter’s earnings estimate for HSIC is $1.28 with a range of $1.24 to $1.30. The previous quarter’s EPS was $1.10. HSIC beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year HSIC has Preformed in-line its overall industry.

HSIC Sales Forecast

Next quarter’s sales forecast for HSIC is $3.28B with a range of $3.21B to $3.31B. The previous quarter’s sales results were $3.24B. HSIC beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year HSIC has Preformed in-line its overall industry.

HSIC Stock Forecast FAQ

What is HSIC’s average 12-month price target, according to analysts?

Based on analyst ratings, Henry Schein’s 12-month average price target is 75.00.

What is HSIC’s upside potential, based on the analysts’ average price target?

Henry Schein has 13.57% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HSIC a Buy, Sell or Hold?

Henry Schein has a consensus rating of Moderate Buy which is based on 5 buy ratings, 7 hold ratings and 0 sell ratings.

What is Henry Schein’s price target?

The average price target for Henry Schein is 75.00. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $83.00 ,the lowest forecast is $70.00. The average price target represents 13.57% Increase from the current price of $66.04.

What do analysts say about Henry Schein?

Henry Schein’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of HSIC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Henry Schein (HSIC) Stock Forecast & Price Target

HSIC Analyst Ratings

HSIC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Henry Schein

HSIC Analyst Recommendation Trends

HSIC Financial Forecast

HSIC Earnings Forecast

HSIC Sales Forecast

HSIC Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts